Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Skinvisible (SKVI) Long-Term Deferred Tax (2018 - 2025)

Skinvisible (SKVI) has disclosed Long-Term Deferred Tax for 8 consecutive years, with $8.6 million as the latest value for Q4 2025.

  • Quarterly Long-Term Deferred Tax rose 2.38% to $8.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $8.6 million through Dec 2025, up 2.38% year-over-year, with the annual reading at $8.6 million for FY2025, 2.38% up from the prior year.
  • Long-Term Deferred Tax hit $8.6 million in Q4 2025 for Skinvisible, up from $8.4 million in the prior quarter.
  • In the past five years, Long-Term Deferred Tax ranged from a high of $8.6 million in Q4 2025 to a low of $3.3 million in Q4 2021.
  • Historically, Long-Term Deferred Tax has averaged $7.3 million across 5 years, with a median of $8.3 million in 2023.
  • Biggest five-year swings in Long-Term Deferred Tax: soared 136.36% in 2022 and later increased 1.2% in 2024.
  • Year by year, Long-Term Deferred Tax stood at $3.3 million in 2021, then surged by 136.36% to $7.8 million in 2022, then grew by 6.41% to $8.3 million in 2023, then increased by 1.2% to $8.4 million in 2024, then increased by 2.38% to $8.6 million in 2025.
  • Business Quant data shows Long-Term Deferred Tax for SKVI at $8.6 million in Q4 2025, $8.4 million in Q4 2024, and $8.3 million in Q4 2023.